Comerica Bank’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$5.62K Hold
664
﹤0.01% 3381
2025
Q3
$3.47K Hold
664
﹤0.01% 3461
2025
Q2
$2.3K Hold
664
﹤0.01% 3486
2025
Q1
$1.74K Buy
664
+629
+1,797% +$2.46K ﹤0.01% 3503
2024
Q4
$144 Buy
+35
New +$190 ﹤0.01% 3644
2024
Q1
Sell
-227
Closed -$2.5K 3811
2023
Q4
$2.5K Sell
227
-4
-2% -$34 ﹤0.01% 3473
2023
Q3
$1.94K Buy
+231
New +$2.48K ﹤0.01% 3577

Other funds holding RLAY

Comerica Bank's RLAY Position: Q4 2025 in Review

Comerica Bank held its Relay Therapeutics (RLAY) position steady in Q4 2025 at 664 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3381.

Comerica Bank first reported a position in RLAY in Q3 2023 and has held it in 7 quarters since. 226 funds tracked by Wall St. Rank hold RLAY as of Q4 2025.

  • Comerica Bank held 664 shares of Relay Therapeutics worth $5.62K as of Q4 2025.
  • Comerica Bank left its Relay Therapeutics share count unchanged in Q4 2025.
  • Relay Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3381 holding.
  • Comerica Bank first reported a position in Relay Therapeutics in Q3 2023 and has held it in 7 quarters since.
  • 226 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.